The property developer has backed Chinese Academy of Medical Sciences spinout Juventas to help advance its clinical-stage oncology cell therapy candidates.
Juventas, a China-based immunotherapy developer based on research at Chinese Academy of Medical Sciences, raised $65m in funding on Wednesday.
The company did not identify investors, however, DealStreetAsia reported it was led by private equity fund CMG-SDIC Capital and backed by commercial property developer Parkland Group.
The round also included Kaixin Biotechnology – possibly part of automotive retailer Kaixin Auto – Tzitzit Asset, Tianjin Venture Capital, Ruisheng Investment, Xiangrong Capital, Dalton Venture and Jiadao…
The company did not identify investors, however, DealStreetAsia reported it was led by private equity fund CMG-SDIC Capital and backed by commercial property developer Parkland Group.
The round also included Kaixin Biotechnology – possibly part of automotive retailer Kaixin Auto – Tzitzit Asset, Tianjin Venture Capital, Ruisheng Investment, Xiangrong Capital, Dalton Venture and Jiadao…
LEADERSHIP SOCIETY
Informing, connecting, and transforming the global corporate venture capital ecosystem.The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
More featured content
2024 marks flurry of university spinout fund launches
2024 marks flurry of university spinout fund launches
University venture funds are becoming an increasingly important tool for universities to support their ecosystems — here are the new ones launched in 2024.
